NantHealth Company Profile (NYSE:NH)

About NantHealth (NYSE:NH)

NantHealth logoNantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient's tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Software & Technology Services
  • Sub-Industry: N/A
  • Symbol: NYSE:NH
  • CUSIP: N/A
  • Web: nanthealth.com/
Capitalization:
  • Market Cap: $365.84 million
  • Outstanding Shares: 121,964,000
Average Prices:
  • 50 Day Moving Avg: $4.00
  • 200 Day Moving Avg: $4.52
  • 52 Week Range: $2.90 - $15.80
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.82
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $98.18 million
  • Price / Sales: 3.73
  • Book Value: $2.46 per share
  • Price / Book: 1.22
Profitability:
  • EBIDTA: ($116,130,000.00)
  • Net Margins: -267.11%
  • Return on Equity: -83.97%
  • Return on Assets: -46.64%
Misc:
  • Average Volume: 202,680 shs.
  • Short Ratio: 21.41
 

Frequently Asked Questions for NantHealth (NYSE:NH)

What is NantHealth's stock symbol?

NantHealth trades on the New York Stock Exchange (NYSE) under the ticker symbol "NH."

How were NantHealth's earnings last quarter?

NantHealth Inc (NYSE:NH) issued its earnings results on Thursday, August, 10th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.26) by $0.32. The company earned $26.23 million during the quarter, compared to analysts' expectations of $31.28 million. NantHealth had a negative net margin of 267.11% and a negative return on equity of 83.97%. The company's quarterly revenue was down 16.7% on a year-over-year basis. During the same period last year, the business posted ($0.15) earnings per share. View NantHealth's Earnings History.

Where is NantHealth's stock going? Where will NantHealth's stock price be in 2017?

4 equities research analysts have issued twelve-month target prices for NantHealth's stock. Their predictions range from $5.50 to $13.00. On average, they anticipate NantHealth's stock price to reach $9.38 in the next year. View Analyst Ratings for NantHealth.

What are analysts saying about NantHealth stock?

Here are some recent quotes from research analysts about NantHealth stock:

  • 1. According to Zacks Investment Research, "Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets of molecular, clinical, operational and financial data points derived from novel and traditional sources. Nant Health, LLC is based in CULVER CITY, United States. " (4/6/2017)
  • 2. Cantor Fitzgerald analysts commented, "NantHealth shares are trading lower by about 18% today. The weakness is probably related to a negative article published at StatNews.com. The article claims that Dr. Patrick Soon-Shiong, Nanthealth's CEO, donated $12 million to the University of Utah. In return for the contribution, the article suggests that the University was committed to spend $10 million in "Omics Analysis". As noted above, the company disclosed on its 3Q16 conference call that the company did not recognize revenue related to 180 sequences ordered by the University of Utah. The article also tries to indicate that the company overstated the number of GPS Cancer tests it reported. It claims the orders from the University of Utah were for sequences, not for GPS Cancer tests. While the tests completed were used for preclinical research, the GPS Cancer test is a sequence by definition. Accordingly, we have no problem with the company classifying the Utah orders as GPS Cancer tests given the disclosure and the fact that it did not recognize revenue from the tests." (3/6/2017)

Who are some of NantHealth's key competitors?

Who are NantHealth's key executives?

NantHealth's management team includes the folowing people:

  • Patrick Soon-Shiong M.D., Chairman of the Board, Chief Executive Officer, Founder
  • Paul A. Holt, Chief Financial Officer
  • Michael D. Blaszyk, Independent Director
  • Mark Burnett, Independent Director
  • Kirk K. Calhoun, Independent Director
  • Michael S. Sitrick, Independent Director

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

Who owns NantHealth stock?

NantHealth's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Emerald Advisers Inc. PA (0.40%), Emerald Mutual Fund Advisers Trust (0.37%), Vanguard Group Inc. (0.35%), Wildcat Capital Management LLC (0.20%), Goldman Sachs Group Inc. (0.14%) and FMR LLC (0.14%). Company insiders that own NantHealth stock include Healthcare Solution Allscripts and Patrick Soon-Shiong. View Institutional Ownership Trends for NantHealth.

Who sold NantHealth stock? Who is selling NantHealth stock?

NantHealth's stock was sold by a variety of institutional investors in the last quarter, including Emerald Advisers Inc. PA, FMR LLC and ProShare Advisors LLC. View Insider Buying and Selling for NantHealth.

Who bought NantHealth stock? Who is buying NantHealth stock?

NantHealth's stock was purchased by a variety of institutional investors in the last quarter, including National Planning Corp, Northern Trust Corp, Goldman Sachs Group Inc., Vanguard Group Inc., State Street Corp, DekaBank Deutsche Girozentrale, Bank of New York Mellon Corp and GSA Capital Partners LLP. Company insiders that have bought NantHealth stock in the last two years include Healthcare Solution Allscripts and Patrick Soon-Shiong. View Insider Buying and Selling for NantHealth.

How do I buy NantHealth stock?

Shares of NantHealth can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NantHealth's stock price today?

One share of NantHealth stock can currently be purchased for approximately $3.00.


MarketBeat Community Rating for NantHealth (NYSE NH)
Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  90 (Vote Outperform)
Underperform Votes:  51 (Vote Underperform)
Total Votes:  141
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for NantHealth (NYSE:NH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.38 (212.50% upside)

Analysts' Ratings History for NantHealth (NYSE:NH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/21/2017Canaccord GenuityReiterated RatingBuy$8.00 -> $6.00LowView Rating Details
6/19/2017Jefferies Group LLCReiterated RatingBuy$8.00 -> $5.50LowView Rating Details
4/3/2017Cantor FitzgeraldLower Price TargetOverweight$15.00 -> $13.00HighView Rating Details
4/1/2017FBR & CoSet Price TargetBuy$13.00HighView Rating Details
6/27/2016First AnalysisInitiated CoverageOverweight$18.00N/AView Rating Details
6/27/2016Cowen and CompanyInitiated CoverageOutperform$19.00N/AView Rating Details
(Data available from 8/23/2015 forward)

Earnings

Earnings History for NantHealth (NYSE:NH)
Earnings by Quarter for NantHealth (NYSE:NH)
Earnings History by Quarter for NantHealth (NYSE NH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/10/2017Q2 2017($0.26)($0.58)$31.28 million$26.23 millionViewN/AView Earnings Details
5/10/2017Q1 2017($0.20)($0.24)$29.06 million$22.51 millionViewN/AView Earnings Details
3/30/2017Q4 2016($0.19)($0.18)$30.02 million$24.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NantHealth (NYSE:NH)
2017 EPS Consensus Estimate: ($0.28)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.14)($0.14)($0.14)
Q2 20171($0.07)($0.07)($0.07)
Q3 20171($0.04)($0.04)($0.04)
Q4 20171($0.03)($0.03)($0.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for NantHealth (NYSE:NH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for NantHealth (NYSE:NH)
Insider Trades by Quarter for NantHealth (NYSE:NH)
Institutional Ownership by Quarter for NantHealth (NYSE:NH)
Insider Trades by Quarter for NantHealth (NYSE:NH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/7/2016Healthcare Solution AllscriptsMajor ShareholderBuy714,286$14.00$10,000,004.00View SEC Filing  
6/7/2016Patrick Soon-ShiongCEOBuy357,143$14.00$5,000,002.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for NantHealth (NYSE:NH)
Latest Headlines for NantHealth (NYSE:NH)
Source:
DateHeadline
americanbankingnews.com logoNantHealth Inc (NH) Earns "Buy" Rating from Canaccord Genuity
www.americanbankingnews.com - August 21 at 4:08 PM
finance.yahoo.com logoNantHealth, Inc. breached its 50 day moving average in a Bearish Manner : NH-US : August 10, 2017
finance.yahoo.com - August 12 at 6:15 AM
latimes.com logoNantHealth to cut 300 employees, will sell some assets to Allscripts
www.latimes.com - August 11 at 5:47 PM
businesswire.com logoNantHealth Reports 2017 Second Quarter Financial Results; Implements Plan to Focus on Core Competencies, Enhance Profitability and Position for Growth of Artificial ...
www.businesswire.com - August 11 at 6:52 AM
finance.yahoo.com logoNantHealth Reports 2017 Second Quarter Financial Results; Implements Plan to Focus on Core Competencies, Enhance Profitability and Position for Growth of Artificial Intelligence for Cancer Care
finance.yahoo.com - August 11 at 6:52 AM
finance.yahoo.com logoEdited Transcript of NH earnings conference call or presentation 10-Aug-17 8:30pm GMT
finance.yahoo.com - August 11 at 6:52 AM
americanbankingnews.com logoNantHealth Inc (NYSE:NH) Issues Earnings Results
www.americanbankingnews.com - August 10 at 10:42 PM
finance.yahoo.com logoNantHealth to Report 2017 Second-Quarter Financial Results and Host Conference Call on Thursday, August 10
finance.yahoo.com - August 9 at 3:40 AM
finance.yahoo.com logoNantHealth Continues Global Expansion of GPS Cancer™ by Bringing Advanced Genomic Profiling to Patients in Mexico
finance.yahoo.com - August 7 at 11:34 PM
americanbankingnews.com logoNantHealth (NH) versus Cotiviti Holdings (COTV) Head-To-Head Comparison
www.americanbankingnews.com - August 5 at 4:18 PM
americanbankingnews.com logoContrasting Press Ganey Holdings (PGND) & NantHealth (NYSE:NH)
www.americanbankingnews.com - August 5 at 2:22 PM
nasdaq.com logoNantHealth Signs Three-Year Extension Contract With Blue Cross and Blue Shield of Nebraska
www.nasdaq.com - August 2 at 6:18 AM
finance.yahoo.com logoNantHealth Announces Three-Year Contract Extension with Long-Time Client Blue Cross and Blue Shield of Nebraska
finance.yahoo.com - August 2 at 6:18 AM
finance.yahoo.com logoETFs with exposure to NantHealth, Inc. : August 1, 2017
finance.yahoo.com - August 2 at 6:18 AM
americanbankingnews.com logoComparing Allscripts Healthcare Solutions (MDRX) and NantHealth (NH)
www.americanbankingnews.com - August 1 at 8:58 AM
americanbankingnews.com logoFinancial Analysis: NantHealth (NH) vs. Evolent Health (EVH)
www.americanbankingnews.com - July 31 at 10:04 AM
finance.yahoo.com logoETFs with exposure to NantHealth, Inc. : June 27, 2017
finance.yahoo.com - June 27 at 6:56 PM
americanbankingnews.com logoAnalyzing NantHealth (NH) and Omnicell (OMCL)
www.americanbankingnews.com - June 25 at 2:14 PM
americanbankingnews.com logoJefferies Group LLC Reaffirms Buy Rating for NantHealth Inc (NH)
www.americanbankingnews.com - June 19 at 5:04 PM
finance.yahoo.com logoETFs with exposure to NantHealth, Inc. : June 15, 2017
finance.yahoo.com - June 16 at 8:07 AM
finance.yahoo.com logoNantHealth, Inc. breached its 50 day moving average in a Bullish Manner : NH-US : June 14, 2017
finance.yahoo.com - June 14 at 9:17 AM
americanbankingnews.com logoNantHealth (NH) & Tabula Rasa HealthCare (TRHC) Head-To-Head Analysis
www.americanbankingnews.com - June 11 at 8:34 AM
finance.yahoo.com logoETFs with exposure to NantHealth, Inc. : June 5, 2017
finance.yahoo.com - June 5 at 7:27 PM
businesswire.com logoNantHealth to Present at the Jefferies Healthcare Conference on June 7, 2017 - Business Wire (press release)
www.businesswire.com - June 2 at 8:13 PM
finance.yahoo.com logoNantHealth to Present at the Jefferies Healthcare Conference on June 7, 2017
finance.yahoo.com - June 2 at 8:13 PM
finance.yahoo.com logoNantHealth, Inc. :NH-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017
finance.yahoo.com - June 2 at 8:13 PM
americanbankingnews.com logoNantHealth Inc (NH) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 2 at 2:08 PM
businesswire.com logoScott+Scott, Attorneys at Law, LLP Announces Investigation into ... - Business Wire (press release)
www.businesswire.com - June 1 at 7:39 PM
finance.yahoo.com logoNH EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class ...
finance.yahoo.com - May 28 at 12:11 AM
streetinsider.com logoNantHealth (NH) Names Ronald A. Louks as COO
www.streetinsider.com - May 23 at 10:15 AM
finance.yahoo.com logoNantHealth Names Ronald A. Louks as Chief Operating Officer
finance.yahoo.com - May 23 at 10:15 AM
businesswire.com logoScott+Scott, Attorneys at Law, LLP Announces Investigation into NantHealth, Inc. (NASDAQ: NH) - Business Wire (press release)
www.businesswire.com - May 20 at 8:21 AM
finance.yahoo.com logoScott+Scott, Attorneys at Law, LLP Announces Investigation into NantHealth, Inc. (NASDAQ: NH)
finance.yahoo.com - May 19 at 11:33 AM
finance.yahoo.com logoEdited Transcript of NH earnings conference call or presentation 10-May-17 8:30pm GMT
finance.yahoo.com - May 16 at 10:14 AM
americanbankingnews.com logoNantHealth Inc (NH) Announces Earnings Results
www.americanbankingnews.com - May 10 at 9:14 PM
finance.yahoo.com logoInvestor Network: NantHealth, Inc. to Host Earnings Call
finance.yahoo.com - May 10 at 7:00 PM
finance.yahoo.com logoNantHealth Reports 16% Increase in 2017 First Quarter Total Net Revenue; SaaS Revenue Rose 11% and GPS Adoption Continues to Climb
finance.yahoo.com - May 10 at 7:00 PM
finance.yahoo.com logoNantHealth Appoints Dr. Sandeep Reddy as Chief Medical Officer
finance.yahoo.com - May 10 at 12:06 PM
finance.yahoo.com logoNantHealth to Report 2017 First-Quarter Financial Results and Host Conference Call on Wednesday, May 10
finance.yahoo.com - May 9 at 11:33 AM
americanbankingnews.com logoNantHealth Inc (NH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 8 at 2:44 PM
finance.yahoo.com logoDEADLINE TODAY: Levi & Korsinsky, LLP Reminds Shareholders of a Complaint to Recover Losses Suffered by Investors in NantHealth, Inc. -- Lead Plaintiff Deadline of May 8, 2017 -- NH
finance.yahoo.com - May 8 at 12:20 PM
finance.yahoo.com logoDEADLINE TODAY: Lundin Law PC Announces Securities Class Action Lawsuit against NantHealth, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 8 at 12:20 PM
finance.yahoo.com logoNANTHEALTH 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against NantHealth, Inc. – (NH)
finance.yahoo.com - May 6 at 12:08 AM
finance.yahoo.com logoMAY 8 DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against NantHealth, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 6 at 12:08 AM
finance.yahoo.com logoUPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving NantHealth, Inc. and a Lead Plaintiff Deadline of May 8, 2017 - NH
finance.yahoo.com - May 5 at 7:07 PM
finance.yahoo.com logoScott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming May 8th Deadline to File for Lead Plaintiff in Class Action Lawsuit against NantHealth, Inc. (NASDAQ: NH)
finance.yahoo.com - May 5 at 7:07 PM
finance.yahoo.com logoMONDAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against NantHealth, Inc. and Reminds Investors with Losses to Contact the Firm
finance.yahoo.com - May 4 at 11:58 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of a Complaint to Recover Losses Suffered by Investors in NantHealth, Inc. and Lead Plaintiff Deadline of May 8, 2017 -- NH
finance.yahoo.com - May 4 at 6:54 PM
finance.yahoo.com logoBragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NantHealth, Inc. (NH) and Encourages Investors with Losses to Contact the Firm Before May 8, 2017
finance.yahoo.com - May 4 at 6:54 PM
americanbankingnews.com logoNantHealth Inc (NH) Short Interest Down 3.9% in April
www.americanbankingnews.com - May 4 at 1:01 AM

Social

Chart

NantHealth (NH) Chart for Wednesday, August, 23, 2017

This page was last updated on 8/23/2017 by MarketBeat.com Staff